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Familial Alzheimer's disease (FAD)-causing mutations in presenilins were shown to alter intracellular
calcium dynamics, including store-operated calcium entry (SOCE). However, the involvement of FAD-
linked amyloid precursor protein (APP) in SOCE remains controversial. Here, we used gain-of-function
and loss-of-function approaches to shed light on this issue. We found that Jurkat cells, which exhibit
prominent SOCE mediated by Orai channels, maintain low APP levels. The ectopic expression of APP,
either with wildtype sequence or FAD-causing Swedish mutation, had no effect on SOCE induced by
calcium store depletion with cyclopiazonic acid (CPA). The overproduction of C99 fragments, mimicking
amyloidogenic processing of APP, also had no effect. Moreover, there was no alteration in the CPA-evoked
SOCE upon APP knockdown in HeLa cells, which natively express 100-fold more APP than Jurkat cells.
Consistently, we found no evidence for APP-dependent changes in the mRNA or protein levels of main
SOCE components. Altogether, these results suggest that APP does not modulate Orai-dependent SOCE
following quantitative calcium store depletion.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Alzheimer's disease (AD) is the most common neurodegenera-
tive disorder. Early-onset familial AD (FAD) cases are caused by
mutations in the genes that encode presenilin-1 (PS1), presenilin-2,
and amyloid precursor protein (APP) [1,2]. Presenilins constitute
the enzymatic component of g-secretase, which processes various
integral membrane proteins, including APP [3]. The amyloidogenic
processing of APP begins with cleavage by b-secretase, yielding the
C99 fragment [2]. Subsequent cleavage by g-secretase leads to the
formation of Ab peptides and APP intracellular C-terminal domain
(AICD). Alternatively, in non-amyloidogenic processing, cleavage by
a-secretase precludes b-amyloid formation and gives rise to the
C83 fragment. FAD mutations favor amyloidogenic processing and
an increase in Ab42/Ab40 ratios [1].
The prevalent b-amyloid cascade hypothesis of AD assumes that
the accumulation of Ab plaques or oligomers is the pathogenic
factor. However, all Ab-targeting treatments have failed in clinical
trials [4]. One of the alternative hypotheses suggests that the dys-
regulation of neuronal calcium (Ca2þ) homeostasis is the majorrski).
Inc. This is an open access article ucause of AD [4e6]. This calcium hypothesis of AD is supported by
experimental work in animal and cell models. Importantly, FAD-
PS1 cells, both of neuronal and non-neuronal origin, have been
shown to exhibit enhanced Ca2þ release through inositol 1,4,5-
trisphosphate (IP3) receptors from the endoplasmic reticulum
(ER), which is the main intracellular Ca2þ store [7,8]. This upregu-
lation of ER Ca2þ signaling might lead to aberrant synaptic trans-
mission and neuronal cell death. The work in many laboratories,
including ours, has shown that PS1 FAD mutations also reduce
store-operated Ca2þ entry (SOCE) [9e13]. Conversely, the attenu-
ation of g-secretase activity increases SOCE [11,12,14,15]. SOCE is
triggered by ER Ca2þ store depletion, resulting in subsequent Ca2þ
inﬂux from the extracellular space [16]. The ER Ca2þ sensing
function is provided by closely-related stromal interaction mole-
cule 1 (STIM1) and STIM2 proteins. Upon Ca2þ depletion from the
ER, STIM proteins oligomerize and translocate to the ER-plasma
membrane junctions, where they activate highly selective Ca2þ
channels that are composed of Orai1-3 subunits [16]. In some cells,
notably in astrocytes, channels from the canonical transient re-
ceptor potential (TRPC) family may contribute to SOCE [17]. STIM1/
Orai1-mediated SOCE constitutes the major Ca2þ entry mechanism
in non-excitable cells, and accumulating evidence points to an
important role of SOCE also in neurons [18]. In particular, recent
work demonstrated that neuronal SOCE is required for spinender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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[13,19].
Comparedwith PS1, the involvement of APP and its FADmutants
in intracellular Ca2þ homeostasis has been less studied. Their Ca2þ-
related functions appear to be carried out by g-secretase processed
products. Ab oligomers may increase Ca2þ entry, whereas AICD was
implicated in ER Ca2þ signaling [5]. The role of APP in SOCE is
confusing. Ablation of APP expression was reported to reduce SOCE
in astrocytes [20]. APP FADmutations were shown both to enhance
SOCE [21] and to attenuate it [19]. Others have found no evidence
that APP, APP FAD mutants, or Ab is involved in the regulation of
SOCE [9,11,22,23]. The aim of the present study was to reinvestigate
the role of APP, APP FAD mutants and cleavage products in cells
with proven Orai-dependent SOCE.
2. Materials and methods
2.1. Reagents and plasmids
Cyclopiazonic acid (CPA), DAPT, polybrene and poly-L-lysine
(PLL) were obtained from Sigma-Aldrich. Fura-2/AM and Fura-4F/
AM were obtained from Life Technologies. Human APP and ORAI1
coding sequences originated from Addgene plasmids #30137,
#30145 and #22754, and were cloned MluI-NotI into a modiﬁed
pLVTH vector (Addgene #12262), in which eGFP and the H1 pro-
moter were replacedwith an IRES-PURO-WPRE cassette. The short-
hairpin RNAs (shRNA; see Supplementary materials) were cloned
into a pSUPER.retro vector (Oligoengine) or into a modiﬁed pLVTH
vector, in which eGFP was replaced with a puromycin selection
marker.
2.2. Cell cultures, virus production, and transduction
Jurkat E6-1, 293T/17 and HeLa cells were obtained from ATCC.
293T/17 and HeLa cells were grown in Dulbecco's Modiﬁed Eagle
Medium and Jurkat cells in RPMI-1640 supplemented with 10 mM
HEPES. All media contained 10% FBS. For virus production, 293T/
17 cells were transfected with transfer and helper plasmids using
the Ca2þ-phosphate method. Supernatants were collected 48 h
after transfection, ﬁltered through 0.45-mm cellulose acetate
membranes and concentrated in Vivaspin 100-kDa units (Sartorius)
in a swing-out rotor at 1,000g. Functional viral titers were
determined by transducing HeLa cells with serial dilutions of viral
preparations. Cells were transduced in the presence of 4e8 mg/ml
polybrene and selected with 1e2 mg/ml (HeLa) or 0.5 mg/ml (Jurkat)
puromycin.
2.3. qPCR
RNAwas isolated using the RNeasyPlus Mini kit (Qiagen). cDNAs
were produced with SuperScript III Reverse Transcriptase (Life
Technologies) and ampliﬁed (20 ng input RNA) using a 7900HT
Real-Time PCR system (Applied Biosystems) with SYBR Green
chemistry. For each primer pair (see Supplementary materials), a
standard curve was prepared using serial dilutions of cDNAs.
Analyzed mRNAs were normalized to GAPDH mRNAs, and relative
levels were calculated using SDS 2.4 software. One n is deﬁned as
one independent RNA/cDNA preparation quantiﬁed 1e2 times by
qPCR.
2.4. Measurements of SOCE
Cells attached on PLL-coated coverslips were loaded with Fura-
2/AM or Fura-4F/AM in bath solution containing: 150 mM NaCl,
6 mM KCl, 1 mMMgCl2, 2 mM CaCl2, 10 mM glucose, 10 mMHEPES,pH 7.4. SOCE measurements were performed under perfusion with
bath solution at 25 C. Stores were depleted with Ca2þ-free bath
solution supplemented with 20 mMCPA and (for HeLa cells) 0.5 mM
EGTA. One n is deﬁned as one measurement. For more details, see
Supplementary methods.
2.5. FACS
Cells were washed in PBS and ﬁxed with 2% paraformaldehyde
in PBS. Blocking was performed in PBS containing 2% normal
donkey serum and 0.2% saponin. The cells were stained with Y188
antibodies (1:500) in blocking solution, and washed two times in
PBS. Subsequently, they were stained with Alexa Fluor 488-
conjugated antibodies (1:1000) in blocking solution and washed
two times in PBS. One reaction contained 1  106 cells. The signals
were collected using a FACSCalibur ﬂow cytometer (BD Bio-
sciences). Data were analyzed using Flowing Software.
2.6. Statistical analysis
The data were analyzed in Excel or GraphPad Prism using two-
tailed unpaired or one-sample t-test, as indicated. The calculated
mean values are shown as bars with standard errors. Values of
p < 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Jurkat cells express the APP gene at low levels
Inspection of the gene expression databases revealed that APP is
abundantly expressed with the exception of leukocytes. Although
some studies have reported detectable APP mRNA levels in T-cells
[24], especially following stimulation, others found no evidence for
APP presence in lymphocytes [25]. By screening various cultured
cell lines, we found that Jurkat cells, which originated from a pa-
tient with acute T-cell leukemia, apparently lacked any APP. Neither
of two established APP antibodies, 22C11 (which recognizes the N-
terminal extracellular domain) and Y188 (which recognizes the
intracellular C-terminal tail), detected full-length APP in lysates
that were prepared from Jurkat cells, whereas both antibodies
clearly indicated APP presence in two commonly used cell lines,
HeLa and HEK 293T/17 (Fig.1A). The lack of APP in Jurkat cell lysates
may result from very fast proteolysis or low gene expression.
Therefore, APP expressionwas quantiﬁed by qPCR using two primer
pairs that are predicted to anneal to all known splicing isoforms,
including the L-APP isoform that was found in T-cells [24]. Both
primer pairs gave very consistent results for APP mRNA levels in
Jurkat cells, with 95% conﬁdence intervals of 0.37e1.18% and
0.34e1.15% for each primer pair, respectively, for the levels that
were calculated for HeLa cells (Fig. 1B). The results allowed us to
conclude that APP gene expression in Jurkat cells was two orders of
magnitude lower than in HeLa cells and is likely themain reason for
the undetectable APP signal in Jurkat cell lysates. Therefore, Jurkat
cells were deemed an appropriate system for further functional
studies with overexpressed APP variants, because it avoids inter-
ference from endogenously produced APP.
3.2. Generation of Jurkat cell lines that stably produce ectopic APP
To generate cell lines stably producing APP variants, Jurkat cells
were transduced with viruses that carried cDNAs coding for APP
(isoform 695, a predominant isoform in neuronal cells), APP with
the K670N/M671L Swedish double mutation (APPSWE), or empty
cassette, as control. The Swedish mutation is known to facilitate
processing at the b-site, thereby favoring the amyloidogenic
Fig. 1. Generation of Jurkat cell lines stably producing APP. (A) Immunoblot of
endogenous APP in Jurkat, 293T/17, and HeLa cells carrying APP-targeting shRNA (APP
KD) or control shRNA. (B) qPCR analysis of relative APP mRNA levels in cells presented
in (A). Differences from the reference level of 1 set for HeLa control cells were analyzed
using one-sample t-test (n ¼ 4 each). Signiﬁcant differences are marked with asterisks
(***p < 0.001). (C) Immunoblot of APP, Orai1, and STIM1 in Jurkat cells stably
expressing APP, APPSWE or an empty cassette (control), compared with wildtype HeLa
cells. (D) FACS analysis of Y188-labeled Jurkat APP cells and APPSWE cells. Y188-labeled
and mock-labeled 293T/17 cells were analyzed in parallel to set a threshold for Y188-
positive cells (horizontal line). The x-axis of both histograms shows the Y188 signal
normalized to cell size (FL1-H/FSC) on a logarithmic scale.
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duction of both APP variants in Jurkat cells at similar levels (Fig. 1C).
As expected, overproduced APP migrated faster than the native
protein in HeLa cells, which likely represents a non-neuronal 751 or
770 isoform. Neither APP variant affected steady-state levels of
endogenous STIM1 or Orai1 proteins, which were clearly more
abundant in all three Jurkat cell lines than in wildtype HeLa cells
(Fig. 1C).
Subsequently, Jurkat cells were labeled with Y188 antibody to
analyze APP levels in individual cells using ﬂuorescence-activated
cell sorting (FACS; Fig. 1D). In parallel, 293T/17 cells that were
labeled with the same antibody or mock-labeled were analyzed to
distinguish between APP-positive and APP-negative cell pop-
ulations. With the threshold set such that all Y188-labeled 293T/
17 cells were regarded as APP-positive, 95% of the Jurkat APP cells
and 93.5% of the Jurkat APPSWE cells were counted as APP-positive,
with the median Y188 signal 2.8- or 2.5-times higher than the
median signal in 293T/17 cells, respectively. Only 7.5% of the Jurkat
control cells were counted as APP-positive, which likely reﬂects
nonspeciﬁc binding of Y188 antibody in these cells. Altogether,these results demonstrate efﬁcient introduction and expression of
the APP cDNAs into Jurkat cells.
3.3. Overexpression of APP or APPSWE in Jurkat cells has no effect on
SOCE upon complete depletion of ER Ca2þ stores
T-cells are capable of substantial SOCE, which not only reﬁlls
Ca2þ stores but also has important signaling functions [16,26]. To
investigate whether APP has any effect on Ca2þ inﬂux through
store-operated channels (SOCs), we utilized an established micro-
scopicmethod tomeasure intracellular Ca2þ dynamics in individual
cells. The transduced Jurkat cells were loaded with the low-afﬁnity
Ca2þ sensor Fura-4F. This probe was chosen for use in Jurkat cells
rather than the widely used high-afﬁnity probe Fura-2 to avoid
saturation of Ca2þ signals during SOCE transients. Subsequently, the
cells were perfused with a Ca2þ-free bath solution containing
20 mM CPA (an inhibitor of SERCA) to fully deplete ER Ca2þ stores,
and a bath solutionwith 2 mM Ca2þwas ﬁnally reapplied to initiate
Ca2þ inﬂux. This protocol aimed at optimal conditions for
measuring SOCE, independent of ER Ca2þ ﬁlling state. Compared
with control Jurkat cells, neither APP-producing cells nor APPSWE-
producing cells presented a signiﬁcantly different SOCE response,
quantiﬁed as the amplitude of the rise in intracellular [Ca2þ] or the
maximal measured inﬂux rate (Fig. 2A). The presence of APP vari-
ants also did not affect SOCE decline rates, indicating unchanged
Ca2þ extrusion mechanisms in responding cells (Supplementary
Fig. 1A). To conﬁrm the dependence of SOCE responses on Orai
channels, the measurements were also conducted on Jurkat cells
that stably produced Orai1 with the E106Q mutation. This pore
mutant exerts a dominant-negative effect (Orai1 DN) on Orai1
channels and presumably also on Orai2 and Orai3 channels [27].
Compared with control cells, Jurkat cells with Orai1 DN exhibited
virtually no SOCE response, quantiﬁed by its amplitude or maximal
inﬂux rate (Fig. 2B). Altogether, these results indicate that neither
APP nor APPSWE affected SOCE in Jurkat cells, and SOCE depended
on Ca2þ inﬂux through Orai channels.
3.4. Overexpression of C99 or C99IND in Jurkat cells does not affect
STIM1/Orai1 levels or SOCE
Oligomeric b-amyloid species, which are derived from APP C99
fragments, have been implicated in increasing Ca2þ entry [5].
However, the immunoblot analysis of small APP fragments from
Jurkat APPSWE cells indicated the presence of the 11-kDa band,
corresponding to the a-processed C83 product, which could be
clearly detected only upon g-secretase inhibition with DAPT
(Fig. 3A). The b-processed C99 fragment was undetectable in lysates
from these cells, suggesting inefﬁcient cleavage by b-secretase and/
or fast further processing. Therefore, two new cell lines were pre-
pared that expressed C99 cDNA with wildtype sequence or an
Indiana mutation (V717F). The Indiana mutation is known to in-
crease the b42/b40 ratio [1], and C99IND cells were expected to
present potential differences in Ca2þ-related functions of these b-
amyloid species. For both cell lines, only the 14-kDa band was
detected in lysates from untreated cells, indicating successful pro-
duction of C99 (Fig. 3B). The treatment of Jurkat C99 cells with
DAPT increased the levels of C99 and, especially, C83, demon-
strating that overproduced C99 can be further processed by a- and
g-secretases (Fig. 3A). The overproduction of C99 or C99IND did not
affect the levels of STIM1 or Orai1 proteins (Fig. 3B). Because
cleavage of C99 by g-secretase liberates AICD, which was impli-
cated in transcriptional regulation [5], the STIM1 and ORAI1 mRNA
levels were quantiﬁed by qPCR. Compared with control cells, no
signiﬁcant differences were detected for C99 or C99IND cells
(Fig. 3C). The cells were subsequently used to measure Ca2þ inﬂux
Fig. 2. Microscopic analysis of SOCE in APP-producing Jurkat cells. (A) SOCE measurements in Fura-4F-loaded Jurkat cells that produced APP (n ¼ 13), APPSWE (n ¼ 12) and control
cells with an empty cassette (n ¼ 13). (B) SOCE measurements in Jurkat cells that produced dominant-negative Orai1 (Orai1 DN; n ¼ 5) and control cells (n ¼ 5). Shown are averaged
traces from representative experiments and calculated mean values with standard error. Differences from control cells were analyzed using unpaired t-test, and signiﬁcant dif-
ferences are marked with asterisks (***p < 0.001).
Fig. 3. Analysis of SOCE in Jurkat cells producing C99 fragments. (A) Immunoblot of small APP fragments (detected with Y188 antibody) in Jurkat cells stably expressing APPSWE, C99
cDNA, or an empty cassette (control) compared with wildtype HeLa cells. DAPT treatment (5 mM for 5 h) is indicated below the gels. (B) Immunoblot of APP, Orai1, and STIM1 in
Jurkat cells stably expressing C99 cDNA, C99IND cDNA, or an empty cassette (control) compared with wildtype HeLa cells. (C) qPCR analysis of ORAI1 and STIM1 mRNA levels in C99-
producing Jurkat cells relative to those in Jurkat control cells. Differences were analyzed using one-sample t-test (n ¼ 3 each). (D) SOCE measurements in Fura-4F-loaded Jurkat
C99 cells (n ¼ 11), C99IND cells (n ¼ 11) and control cells (n ¼ 12). Traces are from representative experiments. The data were analyzed using unpaired t-test.
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surements showed no signiﬁcant differences between Jurkat con-
trol cells and C99 or C99IND cells in SOCE amplitudes, maximal Ca2þ
inﬂux rates (Fig. 3D), or decline rates (Supplementary Fig. 1B).3.5. Knockdown of APP in HeLa cells has no effect on SOCE
To further explore whether APP affects Ca2þ inﬂux via SOCs, we
switched to a loss-of-function approach. The APP expression in
HeLa cells was knocked down by RNA interference. In these cells
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levels in cells with control shRNA (Fig.1B), with concomitant severe
depletion of the protein (Fig. 1A). Upon depletion of ER Ca2þ stores
with CPA, we did not detect any signiﬁcant differences in the
amplitude or in the maximal inﬂux rate of SOCE between Fura-2-
loaded HeLa APP KD cells and control cells (Fig. 4A). The same re-
sults were obtained with HeLa cells transduced with viruses car-
rying another set of APP-targeting and control shRNAs
(Supplementary Fig. 2). In parallel, we used HeLa cells with ORAI1
knockdown (ORAI1 KD), and observed almost complete elimination
of SOCE (Fig. 4A). Therefore, SOCE appeared to be strictly Orai1-
dependent in HeLa cells. The quantiﬁcation of STIM1 and ORAI1
mRNA levels did not reveal any signiﬁcant differences between
HeLa APP KD cells and control cells (Fig. 4B). In HeLa ORAI1 KD cells,
STIM1 mRNA levels remained unchanged, whereas ORAI1 mRNA
levels were reduced, as expected, but only ﬁve-fold (Fig. 4B).
However, this moderate knockdown was sufﬁcient to exert a pro-
found effect on SOCE (Fig. 4A). In sum, these results indicate that
APP is dispensable for SOCE upon complete ER Ca2þ store depletion
in HeLa cells, and corroborate our results obtainedwith the gain-of-
function approach in Jurkat cells.4. Discussion
The present study utilized gain-of-function and loss-of-function
approaches in cultured cells to shed light on the involvement of APP
in SOCE. Speciﬁcally, we used Jurkat cells because they have (i)
undetectable levels of APP, meaning no interference with ectopi-
cally expressed APP variants, (ii) small ER Ca2þ stores, which fa-
cilitates their depletion for SOCE measurements, and (iii) high
expression of SOCE machinery (STIM1/Orai1), resulting in a large
inﬂux of Ca2þ. Prominent SOCE makes the quantiﬁcation of Ca2þ
inﬂux a reliable readout of SOC activity, because it is less likely to be
affected by other Ca2þ inﬂux or extrusion mechanisms. Therefore,
compared to cells with more complex Ca2þ handling machinery
such as neurons, they constitute a simpliﬁed cell system that is well
suited to analyzing this particular Ca2þ response. Although STIM1
and Orai1 proteins are sufﬁcient for SOCE, several proteins have
been recently shown to modulate it [26]. By analogy, we hypoth-
esized that APP or its FAD mutants can affect the properties or
levels of SOCE machinery. However, using ﬂuorescent calcium in-
dicators we did not detect any changes in the CPA-induced SOCE
upon expression of APP or APPSWE in Jurkat cells. Overproduction of
C99 or C99IND fragments, with the aim to mimic amyloidogenic
processing of APP, also had no effect. These results were corrobo-
rated by unchanged SOCE in HeLa cells with APP knockdown.
Consistent with this, we also found no evidence for APP-dependent
changes in the mRNA or protein levels of Orai1 and STIM1 in theFig. 4. Analysis of SOCE in HeLa cells depleted of APP. (A) SOCE measurements in Fura-2-loa
shRNA (ORAI1 KD; n ¼ 3) and control shRNA (control; n ¼ 8). The stores were depleted w
initiated by the re-addition of 2 mM Ca2þ. Shown are averaged (black) and individual (gray) S
test, and signiﬁcant differences from controls are marked with asterisks (***p < 0.001). (B) q
reference level of 1 set for controls were analyzed using one-sample t-test (n ¼ 3 each). Stanalyzed cells.
Our results showing no involvement of APP in SOCE are in
agreement with previous reports. APP overproductionwas found to
have no effect on SOCE induced by SERCA inhibition (with CPA or
thapsigargin) in astrocytes, CHO and neuroblastoma cells
[11,20,23], and APP FAD mutants had no effect on UTP-induced
SOCE in PC12 cells [22]. However, the utilized cells expressed
endogenous APP, which could obscure the molecular phenotype of
ectopic APP. This problemwas alleviated in our experimental model
based on Jurkat cells. Similarly to what we report here for HeLa
cells, SOCE was unchanged in hippocampal neurons lacking APP
[9]. In contrast to these ﬁndings, Linde et al. found a clearly reduced
SOCE in astrocytes with the App gene knock-out [20]. The observed
reduction was attributed to decreased levels of TRPC1, a channel
that contributes to astroglial SOCE [20]. Finally, two studies pre-
sented data for the role of APP harboring the Swedish mutation.
Whereas Niu et al. reported augmentation of SOCE in neural 2a cells
[21], a recent study found an attenuation of SOCE in hippocampal
neurons isolated from FAD-APP knock-in mice [19]. The latter effect
was attributed to increased levels of Ab, resulting in overﬁlled ER
Ca2þ stores, compensatory downregulation of STIM2 expression
and impaired neuronal SOCE. The proposed role of STIM2 in hip-
pocampal SOCE complies with the elevated STIM2/STIM1 ratios in
the hippocampus as compared to other brain regions [28]. The
results of the present study together with the ﬁndings of others
suggest that APP and APP FAD mutants do not directly modulate
SOCE mediated by STIM1 and Orai channels, but they may affect
SOCE responses that rely on other proteins such as STIM2 or TRPC
channels. In contrast, PS1 FAD mutations were shown to reduce
SOCE in numerous cell types, both of neuronal and non-neuronal
origin, although even with PS1 FAD mutants it is not clear
whether they inﬂuence SOCs directly or act indirectly by changing
the ER Ca2þ ﬁlling state [10,13]. Irrespective of exact targets, the
more consistent effects of FAD-PS1 expression may be explained by
the dual mode of action of PS1 that appears to involve not only the
g-cleavage of APP but also g-secretase independent mechanisms.
Nearly identical changes in neuronal Ca2þ handling and spine
morphology have been recently reported by one laboratory for
FAD-APP knock-in mice that strongly accumulated humanized Ab,
and for FAD-PS1 knock-in mice that lacked human Ab altogether
[13,19].
In summary, our data indicate that APP, APPSWE mutant and
amyloidogenic processing fragments do not inﬂuence STIM1/Orai1
levels or Orai-mediated SOCE upon complete ER Ca2þ store deple-
tion. This contrasts with the relatively well-documented effect of
PS1 on SOCE. Our results contribute to a better understanding of
Ca2þ-related functions of FAD-linked proteins.ded HeLa cells stably expressing APP-targeting shRNA (APP KD; n ¼ 8), ORAI1-targeting
ith 20 mM CPA in Ca2þ-free buffer containing 0.5 mM EGTA for 400 s, and SOCE was
OCE traces from representative experiments. The data were analyzed using unpaired t-
PCR analysis of ORAI1 and STIM1 mRNAs in cells presented in (A). Differences from the
atistical signiﬁcance is marked with asterisks (***p < 0.001).
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